Top News

Mandaviya chairs meeting with four states to review elimination of Kala-Azar from by 2023

Union health minister Mansukh Mandaviya on Wednesday chaired a high level meeting to review the status of Kala-Azar disease in the four endemic states of Bihar, Uttar Pradesh, Jharkhand and West Bengal.

“India is committed to eliminating Kala Azar from the country by 2023. 632 (99.8%) endemic blocks have already achieved elimination status (<1 case/10,000). Only one block (Littipara) of Pakur district, Jharkhand is in the endemic category (1.23 case/10,000 population). We are working holistically with the state government and other stakeholders to achieve elimination in Jharkhand”, said Mandaviya while chairing the meeting MoS Health Dr. Bharati Pravin Pawar.

Deputy Chief Minister & Health Minister (Bihar) Tejaswi Yadav, Deputy Chief Minister & Health Minister (Uttar Pradesh), Brajesh Pathak, Health Minister (Jharkhand) Banna Gupta, and senior officers from West Bengal were present at the review meeting.

Mandaviya appreciated the efforts of the State Governments towards meeting elimination target. “Under the visionary leadership of our Prime Minister, it remains our target to ensure health for all of our citizens. Government has taken several steps towards elimination of Kala-Azar by 2023. From interventions like pucca houses through PM-AWAS yojana, rural electrification, timely testing, treatment, periodic high-level review, to incentivizing through award distribution for states/districts/blocks, government along with its stakeholders are ensuring a robust ecosystem for early detection of the disease and its timely treatment”, said Mandaviya.

“While it is commendable that the endemic states are implementing targeted interventions, and some states have eliminated the disease in their districts, it is equally important to sustain the gain and work towards ensuring that the cases stay below 1 case/10,000 population”, said Mandaviya.

He urged the endemic states to ensure that there is a regular review and micro-stratification in high-risk blocks reporting incidence > 0.5 per 10000 populations. “Since Kala-azar impacts those among the lower socio-economic strata of society, early diagnosis & complete case management, integrated control and surveillance along with capacity building of human resource must be taken up on ground level”, he suggested.

States informed about the status of disease in their respective states and shared their best practices too. The State Health Ministers expressed gratitude for the support provided by the Centre for detection, surveillance, treatment through various interventions. Health Ministers of states where elimination status is achieved assured to continue working in Mission mode to ensure that the stats is sustained.

About 90% of global cases of kala Azar were reported from eight countries: Brazil, Eritrea, Ethiopia, India, Kenya, Somalia, South Sudan and Sudan in 2021, with India contributing 11.5% of total cases reported globally. Kala-azar is endemic in 633 blocks of 54 districts in four endemic states of Bihar, Jharkhand, Uttar Pradesh and West Bengal. It is a notifiable disease in these states. Currently more than 90% of the Kala-azar cases are contributed by Bihar and Jharkhand. Uttar Pradesh (2019) and West Bengal (2017) states have achieved their elimination targets at the block level.

Medlarge

Recent Posts

Air pollution spikes inflammation in patients with heart disease: Study

Patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts…

2 days ago

Health ministry writes to all states on alarming air pollution, fire incidents

As the air pollution levels spike and reached alarming levels in many cities across the…

3 days ago

‘Antimicrobial Resistance a global health threat’

Highlighting that Antimicrobial Resistance is a global health threat, the Minister of State for health…

4 days ago

SFI marathon held at Indirapuram

SFI Green Heartfulness Run was held on November 17, 2024 at Indirapuram starting from Habitat…

4 days ago

ICMR starts first in-human clinical trials for Zika vaccine

The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…

2 months ago

Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease

Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…

2 months ago